<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01981083</url>
  </required_header>
  <id_info>
    <org_study_id>217B500602013026</org_study_id>
    <nct_id>NCT01981083</nct_id>
  </id_info>
  <brief_title>Egg Albumin-Based Protein Supplement Versus Renal-specific Supplement in Hemodialysis Patients</brief_title>
  <official_title>Randomized, Open Label, Controlled Clinical Trial of Egg Albumin-Based Protein Supplement Versus Renal Specific Oral Supplement in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Medico Lic Adolfo Lopez Mate</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Medico Lic Adolfo Lopez Mate</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition is seen frequently in hemodialysis units in most developing countries.
      Malnutrition increases morbidity and mortality in this population and its treatment improves
      patient survival and health status The purpose of this study is to compare two strategies to
      improve nutritional status in hemodialysis patients: renal-specific oral supplement (237 ml)
      versus egg albumin-based protein supplement (30 g) on a daily basis.

      This trial uses the Malnutrition Inflammation Score (MIS) and Subjective Global Assessment
      (SGA) in addition to most used biochemical markers to determine nutritional status.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Malnutrition-Inflammation Score</measure>
    <time_frame>Bimonthly, up to six months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Subjective Global Assessment</measure>
    <time_frame>Bimonthly, up to six months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Protein-Energy Malnutrition</condition>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Egg albumin-based protein supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Powder form, dosage 30 g daily, duration 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Renal-specific oral supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Liquid form, dosage 237 ml (one can) daily, duration 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Egg albumin-based protein supplement</intervention_name>
    <arm_group_label>Egg albumin-based protein supplement</arm_group_label>
    <other_name>Pure ProEgg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Renal-specific oral supplement</intervention_name>
    <arm_group_label>Renal-specific oral supplement</arm_group_label>
    <other_name>Enterex Renal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic Kidney Disease in Hemodialysis

        Exclusion Criteria:

          -  Infection

          -  Liver insufficiency

          -  Cancer or neoplasia

          -  Acquired immunodeficiency syndrome

          -  Intestinal malabsorption syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rafael Gonzalez-Toledo, MD</last_name>
    <phone>52(722)2760860</phone>
    <phone_ext>90457</phone_ext>
    <email>rtoledo29@yahoo.com.mx</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro Medico Lic. Adolfo LÃ³pez Mateos</name>
      <address>
        <city>Toluca</city>
        <state>Estado de Mexico</state>
        <zip>50010</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rafael Gonzalez-Toledo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2013</study_first_submitted>
  <study_first_submitted_qc>November 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2013</study_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Medico Lic Adolfo Lopez Mate</investigator_affiliation>
    <investigator_full_name>Rafael Gonzalez-Toledo</investigator_full_name>
    <investigator_title>Affiliated Physician of the Nephrology Service</investigator_title>
  </responsible_party>
  <keyword>Protein-Energy Malnutrition</keyword>
  <keyword>Chronic Kidney Disease</keyword>
  <keyword>Malnutrition-Inflammation Score</keyword>
  <keyword>Subjective Global Assessment</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Egg albumin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Protein-Energy Malnutrition</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

